|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Feb 1, 2025
|
FY2024
12 months to Feb 3, 2024
|
FY2023
12 months to Jan 28, 2023
|
FY2022
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Selling and administrative expenses | |||||
| Goodwill impairment | |||||
| Asset impairments and other, net | |||||
| Operating income (loss) | |||||
| Other components of net periodic benefit cost | |||||
| Interest expense (net of interest income of $0.7 million, $0.7 million and $0.4 million for Fiscal 2026, 2025 and 2024, respectively) | |||||
| Earnings (loss) from continuing operations before income taxes | |||||
| Income tax expense (benefit) | |||||
| Earnings (loss) from continuing operations | |||||
| Gain (loss) from discontinued operations, net of tax | |||||
| Net Earnings (Loss) | |||||
| Basic earnings (loss) per common share: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Net earnings (loss) (in dollars per share) | |||||
| Diluted earnings (loss) per common share: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Net earnings (loss) (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
